191 related articles for article (PubMed ID: 34496895)
1. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.
Gollrad J; Rabsahl C; Riechardt AI; Heufelder J; Stroux A; Goerling U; Joussen A; Budach V; Boehmer D
Radiat Oncol; 2021 Sep; 16(1):174. PubMed ID: 34496895
[TBL] [Abstract][Full Text] [Related]
2. The use of semistructured interviews to assess quality of life impacts for patients with uveal melanoma.
Kopp BC; Crump RT; Weis E
Can J Ophthalmol; 2017 Apr; 52(2):181-185. PubMed ID: 28457288
[TBL] [Abstract][Full Text] [Related]
3. Long-term uveal melanoma survivors: measuring their quality of life.
Frenkel S; Rosenne H; Briscoe D; Hendler K; Bereket R; Molcho M; Pe'er J
Acta Ophthalmol; 2018 Jun; 96(4):e421-e426. PubMed ID: 29369538
[TBL] [Abstract][Full Text] [Related]
4. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
5. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
[TBL] [Abstract][Full Text] [Related]
6. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
7. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
8. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
10. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
11. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
12. Influence of uveal melanoma therapy on patients' quality of life: a psychological study.
Chabert S; Velikay-Parel M; Zehetmayer M
Acta Ophthalmol Scand; 2004 Feb; 82(1):25-31. PubMed ID: 14982042
[TBL] [Abstract][Full Text] [Related]
13. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
14. Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy.
Gollrad J; Rabsahl C; Joussen AM; Stroux A; Budach V; Böhmer D; Böker A
Ocul Oncol Pathol; 2022 Jun; 8(2):110-119. PubMed ID: 35959158
[TBL] [Abstract][Full Text] [Related]
15. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
17. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
19. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients.
Damato B; Hope-Stone L; Cooper B; Brown SL; Salmon P; Heimann H; Dunn LB
Am J Ophthalmol; 2018 Sep; 193():230-251. PubMed ID: 29555484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
